Table 1.
Study population
| Variables | Total | NOV | Endometrial cancer | Ovarian tumors
|
||
|---|---|---|---|---|---|---|
| EOC
|
TOV | |||||
| BOV | LMP | |||||
|
|
|
|
|
|||
| n = 677 | n = 80 | n = 113 | n = 124 | n = 96 | n = 264 | |
| Age at diagnosis | ||||||
|
| ||||||
| Median | 54.5 | 49.0 | 61.0 | 53.0 | 49.5 | 60.0 |
|
| ||||||
| Average | 55.2 | 49.5 | 60.9 | 55.1 | 50.6 | 59.8 |
|
| ||||||
| St. dev. | 12.1 | 8.9 | 11.6 | 13.0 | 15.2 | 11.8 |
|
| ||||||
| Range | 14–91 | 26–78 | 31–83 | 27–91 | 14–80 | 14–89 |
|
| ||||||
| Histopathological subtypes | ||||||
|
| ||||||
| Serous (%) | 290 (59.9) | – | – | 65 (52.4) | 46 (47.9) | 179 (67.8) |
|
| ||||||
| Mucinous (%) | 96 (19.8) | – | – | 40 (32.3) | 48 (50.0) | 8 (3.0) |
|
| ||||||
| Endometrioid (%) | 36 (7.4) | – | – | (0.0) | 1 (1.0) | 35 (13.3) |
|
| ||||||
| Other (%) | 46 (9.5) | – | – | 3 (2.4) | 1 (1.0) | 42 (15.9) |
|
| ||||||
| Unclassified (%) | 209 (3.3) | 80 (100) | 113 (100) | 16 (12.9) | – | – |
|
| ||||||
| Grade | ||||||
|
| ||||||
| Grade 0 (%) | 99 (14.6) | – | – | 3 (2.4) | 95 (99.0) | 1 (0.4) |
|
| ||||||
| Grade 1 (%) | 76 (11.2) | – | 45 (39.8) | 1 (0.8) | 1 (1.0) | 29 (11.0) |
|
| ||||||
| Grade 2 (%) | 82 (12.1) | – | 22 (19.5) | – | – | 60 (22.7) |
|
| ||||||
| Grade 3 (%) | 192 (28.4) | – | 21 (18.6) | – | – | 171 (64.8) |
|
| ||||||
| Missing (%) | 228 (33.7) | 80 (100) | 25 (22.1) | 120 (96.8) | – | 3 (1.1) |
|
| ||||||
| Mortality (n = 85) | ||||||
|
| ||||||
| Grade 0 (%) | – | – | – | – | – | 1 (1.2) |
|
| ||||||
| Grade 1 (%) | – | – | – | – | – | 2 (2.4) |
|
| ||||||
| Grade 2 (%) | – | – | – | – | – | 18 (21.2) |
|
| ||||||
| Grade 3 (%) | – | – | – | – | – | 61 (71.8) |
|
| ||||||
| Missing (%) | – | – | 2 (2.4) | – | – | 1 (1.2) |
|
| ||||||
| Mortality (n = 85) | ||||||
|
| ||||||
| Serous (%) | – | – | – | – | – | 66 (77.6) |
|
| ||||||
| Mucinous (%) | – | – | – | – | – | 0 (0.0) |
|
| ||||||
| Endometrioid (%) | – | – | – | – | – | 6 (7.1) |
|
| ||||||
| Other (%) | – | – | 2 (2.4) | – | – | 11 (12.9) |
NOV: normal ovary; BOV: benign tumor of the ovary; LMP: low malignant potential; TOV: invasive tumor of the ovary; EOC: epithelial ovarian cancer.